You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Overview

Priorix is indicated for the active immunisation of children from the age of 9 months or older, adolescents and adults against measles, mumps and rubella. [1]
For use in children between 9 to 12 months of age please refer to the Summary of Product Characteristics (SPC). [1]

References:

  1. Priorix Summary of Product Characteristics. Available from:https://www.medicines.ie/medicines/priorix-powder-and-solvent-for-solution-for-injection-in-a-pre-filled-syringe-33443/ Last accessed - January 2017

Priorix is a registered trademark of the GlaxoSmithKline group of companies